JP2011006424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011006424A5 JP2011006424A5 JP2010161643A JP2010161643A JP2011006424A5 JP 2011006424 A5 JP2011006424 A5 JP 2011006424A5 JP 2010161643 A JP2010161643 A JP 2010161643A JP 2010161643 A JP2010161643 A JP 2010161643A JP 2011006424 A5 JP2011006424 A5 JP 2011006424A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- pharmaceutical formulation
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 7
- 208000036142 Viral infection Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- 208000010359 Newcastle Disease Diseases 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims 1
- 238000005273 aeration Methods 0.000 claims 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims 1
- 229960003805 amantadine Drugs 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000010805 mumps infectious disease Diseases 0.000 claims 1
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 claims 1
- 229960003752 oseltamivir Drugs 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 229960000329 ribavirin Drugs 0.000 claims 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 claims 1
- 229960000888 rimantadine Drugs 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 229960001028 zanamivir Drugs 0.000 claims 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR8795A AUPR879501A0 (en) | 2001-11-09 | 2001-11-09 | Novel chemical compounds and their use |
| AUPR8795 | 2001-11-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542184A Division JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011006424A JP2011006424A (ja) | 2011-01-13 |
| JP2011006424A5 true JP2011006424A5 (enExample) | 2012-07-26 |
| JP5179546B2 JP5179546B2 (ja) | 2013-04-10 |
Family
ID=3832614
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542184A Expired - Fee Related JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
| JP2010161643A Expired - Fee Related JP5179546B2 (ja) | 2001-11-09 | 2010-07-16 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542184A Expired - Fee Related JP5178989B2 (ja) | 2001-11-09 | 2002-11-08 | 二量体化合物および抗ウイルス薬としてのそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7230028B2 (enExample) |
| EP (1) | EP1451184B1 (enExample) |
| JP (2) | JP5178989B2 (enExample) |
| KR (1) | KR100942493B1 (enExample) |
| CN (1) | CN1301993C (enExample) |
| AT (1) | ATE398123T1 (enExample) |
| AU (1) | AUPR879501A0 (enExample) |
| CA (1) | CA2462345C (enExample) |
| DE (1) | DE60227101D1 (enExample) |
| DK (1) | DK1451184T3 (enExample) |
| ES (1) | ES2305301T3 (enExample) |
| PT (1) | PT1451184E (enExample) |
| WO (1) | WO2003040138A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| SG11201803962WA (en) | 2015-11-20 | 2018-06-28 | Australian Biomedical Co Pty Ltd | Compounds for medicinal applications |
| CN115197583B (zh) | 2017-02-10 | 2024-03-15 | 三菱化学株式会社 | 导电性组合物、导电性组合物的制造方法和导电体的制造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3476455B2 (ja) * | 1991-03-18 | 2003-12-10 | ザ スクリップス リサーチ インスティテュート | ＮｅｕＡｃα２、６Ｇａｌβ１、４ＧｌｃＮＡｃ及びシアリルＬｅｘの合成法 |
| GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
| WO1997032214A1 (en) * | 1996-03-01 | 1997-09-04 | Biota Scientific Management Pty. Ltd. | Method of detection of influenza virus and compounds for use therein |
| AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
-
2001
- 2001-11-09 AU AUPR8795A patent/AUPR879501A0/en not_active Abandoned
-
2002
- 2002-11-08 DK DK02774169T patent/DK1451184T3/da active
- 2002-11-08 JP JP2003542184A patent/JP5178989B2/ja not_active Expired - Fee Related
- 2002-11-08 AT AT02774169T patent/ATE398123T1/de not_active IP Right Cessation
- 2002-11-08 WO PCT/AU2002/001528 patent/WO2003040138A1/en not_active Ceased
- 2002-11-08 PT PT02774169T patent/PT1451184E/pt unknown
- 2002-11-08 CN CNB028222490A patent/CN1301993C/zh not_active Expired - Fee Related
- 2002-11-08 ES ES02774169T patent/ES2305301T3/es not_active Expired - Lifetime
- 2002-11-08 EP EP02774169A patent/EP1451184B1/en not_active Expired - Lifetime
- 2002-11-08 KR KR1020047006445A patent/KR100942493B1/ko not_active Expired - Fee Related
- 2002-11-08 CA CA2462345A patent/CA2462345C/en not_active Expired - Fee Related
- 2002-11-08 US US10/494,241 patent/US7230028B2/en not_active Expired - Fee Related
- 2002-11-08 DE DE60227101T patent/DE60227101D1/de not_active Expired - Lifetime
-
2007
- 2007-05-21 US US11/751,269 patent/US7795301B2/en not_active Expired - Fee Related
-
2010
- 2010-07-16 JP JP2010161643A patent/JP5179546B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010285436A5 (enExample) | ||
| JP2010270130A5 (enExample) | ||
| JP2011528713A5 (enExample) | ||
| JP2017515840A5 (enExample) | ||
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| SI2709613T1 (en) | Procedures for the treatment of HCV | |
| JP2015534562A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| SI2932970T1 (en) | Antiviral therapy | |
| JP2012522001A5 (enExample) | ||
| RU2007119721A (ru) | Частицы для лечения легочной инфекции | |
| JP2014510130A5 (enExample) | ||
| JP2012508256A5 (enExample) | ||
| JP2011006424A5 (enExample) | ||
| JP2014511897A5 (enExample) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| JP2006507295A5 (enExample) | ||
| JP2011500731A5 (enExample) | ||
| CA2462337A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| RU2010120806A (ru) | Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид | |
| CA2463835A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| RU2014136096A (ru) | Лекарственное средство для лечения и профилактики заболеваний верхних и нижних дыхательных путей различной этиологии, его применение и метод лечения на его основе | |
| ES2894330T3 (es) | Acido acetilsalicílico para uso en el tratamiento de la influenza de moderada a grave | |
| JP2011016804A5 (enExample) | ||
| RU2012116226A (ru) | Бронхолитическое средство на основе простагландина |